Why this review matters for FEVR

Familial Exudative Vitreoretinopathy (FEVR) is an inherited retinal disease in which the blood vessels of the retina—the light-sensitive tissue at the back of the eye—do not develop normally. Its effects can vary widely, including within the same family. For children with FEVR, protecting the retina early and responding to signs of disease progression can be especially important.

A 2026 review in Lasers in Medical Science examines progress in laser photocoagulation across a range of pediatric retinal diseases, including FEVR. Rather than reporting results from one new clinical trial, this publication brings together existing knowledge about how laser treatment is used, why it may be effective, and the challenges that remain. For families affected by FEVR, it highlights laser photocoagulation as an established management tool within the broader effort to slow retinal disease and prevent serious complications.

What is laser photocoagulation?

Laser photocoagulation uses focused laser energy to create carefully placed treatment spots on the retina. The review describes this approach as a clinical method designed around the principles and mechanisms of retinal photocoagulation.

In pediatric retinal disease, laser treatment is used to address areas of the retina involved in abnormal disease processes. In the conditions reviewed—including retinopathy of prematurity, FEVR, Coats’ disease, Norrie disease, incontinentia pigmenti, morning glory syndrome, and retinitis pigmentosa—laser therapy has shown important potential to slow disease progression, improve visual function, and help prevent severe complications.

For FEVR, this places laser treatment in a practical context: it is not intended to reverse every retinal change caused by the condition, but it may be used as part of a strategy to manage disease activity and reduce the risk of harmful progression.

Key messages for FEVR care

The central message of the review is that laser photocoagulation can have a meaningful role in pediatric retinal care, but its use must be individualized. Children’s retinal diseases differ in their causes, features, and patterns of progression. Even when two conditions share some similarities, treatment decisions cannot simply be transferred from one disease to another.

For FEVR families, several themes stand out:

  • Laser can be a disease-management tool. The review identifies laser therapy as an approach that can help slow progression and prevent severe complications in pediatric retinal diseases that include FEVR.
  • Treatment requires precision. Laser therapy is not a one-size-fits-all procedure. The review emphasizes the importance of carefully controlling laser parameters during treatment.
  • Potential complications matter. Although laser has demonstrated significant benefits, the authors stress that it can also cause complications. This makes experienced clinical assessment, treatment planning, and follow-up essential.
  • Ongoing monitoring remains important. The need to tailor laser settings and approaches reflects the broader reality that pediatric retinal conditions require careful, continuing care rather than a single uniform intervention.

The publication does not present a new FEVR-specific treatment protocol or identify a single set of laser settings appropriate for every child. Instead, it reinforces the need for clinicians to match the treatment approach to the individual patient and the characteristics of their retinal disease.

What this could mean for treatment today and tomorrow

Today, the review supports laser photocoagulation as a well-recognized treatment approach in the pediatric retinal disease landscape. For FEVR, its potential value lies in helping clinicians intervene when retinal findings suggest a risk of progression or serious complications.

The review also makes clear that effectiveness and safety are closely connected. Laser energy must be sufficient to achieve the intended treatment effect while avoiding unnecessary injury. That balance is particularly important in pediatric care, where retinal disease can be complex and where preserving visual function is a central goal.

Looking ahead, advances in laser technology and additional clinical research may help refine how laser treatment is delivered. Better-defined protocols could support more consistent decision-making, while deeper clinical experience may improve understanding of which patients are most likely to benefit, when treatment should be considered, and how laser parameters can be optimized.

Importantly, future progress will depend on research that specifically addresses the differences among pediatric retinal diseases. FEVR has its own inherited basis and clinical course, so studies that distinguish FEVR from other conditions will be especially valuable.

A growing evidence base for pediatric retinal treatment

This comprehensive review reflects a broader shift toward more informed and technically refined care for childhood retinal disease. Its conclusions are encouraging: laser photocoagulation has demonstrated an ability to slow progression, support visual function, and prevent severe complications across pediatric retinal conditions, including FEVR.

At the same time, the authors underscore that important questions remain. Further research is needed to improve treatment protocols and strengthen effectiveness. For the FEVR community, that continuing work offers a forward-looking message: as technology advances and clinical evidence grows, laser therapy can become increasingly precise within personalized retinal care.